Financials

Discussions Technicals Seasonals

388870 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Pharos iBio Co., Ltd. engages in drug development for rare and refractory diseases. It uses a drug development platform based on big data and artificial intelligence technology. The company was founded on April 19, 2016 and is headquartered in Anyang-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

388870 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company